Research progress and clinical vtility of the ischemia-modified albumin

QIAO Rui,ZHANG Jie
DOI: https://doi.org/10.3969/j.issn.1008-8199.2006.02.027
2006-01-01
Abstract:The ischemia-modified albumin(IMA) forms after the human serum albumin experiences ischmia/reperfusion,which is a novel marker for myocardial ischemia.IMA exhibits a reduced capacity to bind to certain transition metals,such as cobalt.It can be measured by the Albumin Cobalt Binding test in serum.Several clinical researches suggested that IMA is an ideal biomarker for myocardial ischemia and an important assay for diagnosis of acute coronary syndromes.
What problem does this paper attempt to address?